Actively Recruiting
Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia
Led by University Hospital, Toulouse · Updated on 2024-08-02
128
Participants Needed
1
Research Sites
551 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Hypoxemic pneumonia is a major cause of hospitalization in Pulmonology. The patient's dependency on oxygen prevents early discharge from the hospital. An automated oxygen therapy is a system that allows administration of oxygen with a flow that is automatically adjusted to the patient's saturation, which is continuously monitored. This system has proven to be particularly effective with chronic obstructive pulmonary disease (COPD) patients, by decreasing the time spent in hypoxia and hyperoxia, and by accelerating the weaning of oxygen. Our hypothesis is that automated oxygen therapy leads to a diminution on the length of hospital stay.
CONDITIONS
Official Title
Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult
- Patient living at home or in an institution
- Patient hospitalized for less than 48 hours
- Pneumonia defined by respiratory symptoms (cough, sputum, dyspnea, chest pain), hyperthermia >38.56C or hypothermia <366C, and radiological signs
- Hypoxia: SpO2 < 94% in ambient air and/or PaO2 < 60 mmHg in ambient air
You will not qualify if you...
- Pneumonia acquired in the hospital
- Patient hospitalized in another department more than 48 hours before admission
- Chronic respiratory failure
- Active neoplasia
- Patients undergoing oxygen therapy and/or long-term non-invasive ventilation
- Associated cardiac decompensation (clinical signs and/or NTproBNP > 1800 ng/mL)
- Initial need for high flow oxygen therapy or ventilatory support (non-invasive ventilation, invasive ventilation)
- Expected difficulties with home support
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Larrey
Toulouse, France, 31049
Actively Recruiting
Research Team
E
Elise Noel-Savina, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here